These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2499708)

  • 21. [Fluorescence anti-nuclear antibodies (FANA), using cultured human skin fibroblasts as substrate--clinical significance in polymyositis (PM)].
    Yoshimoto Y
    Ryumachi; 1988 Aug; 28(4):214-21. PubMed ID: 3055346
    [No Abstract]   [Full Text] [Related]  

  • 22. Anti-DFS70 antibodies in 597 healthy hospital workers.
    Watanabe A; Kodera M; Sugiura K; Usuda T; Tan EM; Takasaki Y; Tomita Y; Muro Y
    Arthritis Rheum; 2004 Mar; 50(3):892-900. PubMed ID: 15022332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological evaluation of in vivo epidermal nuclear fluorescence.
    Sousa JX; Miyamoto D; Zimbres JM; Costa DV; Aoki V
    Clin Exp Dermatol; 2009 Apr; 34(3):314-8. PubMed ID: 19040522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison between line immunoassay (LIA) and enzyme-linked immunosorbent assay (ELISA) for the determination of antibodies to extractable nuclear antigenes (ENA) with reference to other laboratory results and clinical features].
    Maclachlan D; Vogt P; Wu X; Rose L; Tyndall A; Hasler P
    Z Rheumatol; 2002 Oct; 61(5):534-44. PubMed ID: 12399881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between ANA determinations on tissue substrate, WiL-2 cell substrate, and precipitin antibody by double diffusion.
    Deng JS; Bair LW; Medsger TA; Sontheimer RA
    Diagn Clin Immunol; 1987; 5(3):151-7. PubMed ID: 3121208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Results of studies using the indirect immunofluorescence methods (antinuclear factors) in various rheumatic entities].
    Ripoll Gómez M
    Rev Esp Reum Enferm Osteoartic; 1975; 18(1):65-9. PubMed ID: 1094511
    [No Abstract]   [Full Text] [Related]  

  • 27. Testing for antibodies to ENA and to dsDNA is not indicated in FANA-negative sera.
    Manoussakis MN; Garalea KL; Tzioufas AG; Moutsopoulos HM
    Clin Rheumatol; 1988 Dec; 7(4):465-9. PubMed ID: 3073034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Congenital auriculo-ventricular block with severe fetal repercussions].
    Senga P; Chantepie A; Chergui A; Berger C; Arbeille P; Marchand M; Saliba E; Bloc D; Laugier J
    Ann Pediatr (Paris); 1986 Jun; 33(6):537-41. PubMed ID: 3740729
    [No Abstract]   [Full Text] [Related]  

  • 29. Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis.
    Granito A; Muratori P; Muratori L; Pappas G; Cassani F; Worthington J; Ferri S; Quarneti C; Cipriano V; de Molo C; Lenzi M; Chapman RW; Bianchi FB
    Aliment Pharmacol Ther; 2007 Sep; 26(6):831-8. PubMed ID: 17767467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Rheumatic disease in childhood. Clinical and pathogenetic notes].
    Vaccaro R; Ramenghi M
    Recenti Prog Med; 1971 Jun; 50(6):538-53. PubMed ID: 4944548
    [No Abstract]   [Full Text] [Related]  

  • 31. [Nuclear antibodies as serologic markers in progressive systemic scleroderma].
    Lakomek HJ; Guldner HH; Bautz FA; Goerz G; Kind P; Mensing H; Krüskemper HL
    Hautarzt; 1987 Feb; 38(2):63-9. PubMed ID: 3106261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dysimmune rheumatism in Raynaud's syndrome (inflammatory rheumatism, Raynaud's syndrome, speckled antinuclear factors and anti-ribonucleoprotein antibody): a new syndrome?].
    Appelboom T; Kahn MF; Peltier AP; de SEZE S
    Ann Med Interne (Paris); 1974 Nov; 125(11):841-8. PubMed ID: 4218716
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevalence of anti-SSA (Ro) antibodies in a Mexican population of patients with various systemic rheumatic diseases.
    García-de la Torre I; Sánchez-Guerrero A; Salmón-de la Torre G; Hernández-Vázquez L
    J Rheumatol; 1987 Jun; 14(3):479-81. PubMed ID: 3498034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoantibody testing: procedures and significance in systemic rheumatic diseases.
    Fritzler MJ
    Methods Achiev Exp Pathol; 1986; 12():224-60. PubMed ID: 3083214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of combined antinuclear and anticytoplasmic antibodies detected by immunofluorescence.
    Lee TK; Rothberger H
    Chin Med J (Engl); 1989 Dec; 102(12):911-5. PubMed ID: 2517735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Detection and clinical evaluation of antibodies against soluble nuclear antigens].
    Sánchez-Ibarrola A
    Allergol Immunopathol (Madr); 1983; 11(3):201-6. PubMed ID: 6605081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Optimizing the clinical value of polyreactive autoantibodies to double-stranded DNA].
    Haberhauer G; Chlud K; Isovits D
    Z Gesamte Inn Med; 1989 Nov; 44(21):652-4. PubMed ID: 2692314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transplacental fetal treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease.
    Jaeggi ET; Fouron JC; Silverman ED; Ryan G; Smallhorn J; Hornberger LK
    Circulation; 2004 Sep; 110(12):1542-8. PubMed ID: 15353508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laboratory diagnosis of systemic rheumatic disease.
    Maehara KT
    Am J Med Technol; 1983 Jul; 49(7):477-81. PubMed ID: 6194686
    [No Abstract]   [Full Text] [Related]  

  • 40. Placental transfer of anticytoplasmic antibodies in annular erythema of newborns.
    Miyagawa S; Kitamura W; Yoshioka J; Sakamoto K
    Arch Dermatol; 1981 Sep; 117(9):569-72. PubMed ID: 6794461
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.